BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Burnett T, Mozgunov P, Pallmann P, Villar SS, Wheeler GM, Jaki T. Adding flexibility to clinical trial designs: an example-based guide to the practical use of adaptive designs. BMC Med 2020;18:352. [PMID: 33208155 DOI: 10.1186/s12916-020-01808-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Poncet-Megemont L, Pereira B, Rollot F, Sormani MP, Clavelou P, Moisset X. Estimation of sample size in randomized controlled trials in multiple sclerosis studying annualized relapse rates: A systematic review. Mult Scler 2021;:13524585211052400. [PMID: 34697961 DOI: 10.1177/13524585211052400] [Reference Citation Analysis]
2 Evans JF, Obraztsova K, Lin SM, Krymskaya VP. CrossTORC and WNTegration in Disease: Focus on Lymphangioleiomyomatosis. Int J Mol Sci 2021;22:2233. [PMID: 33668092 DOI: 10.3390/ijms22052233] [Reference Citation Analysis]
3 Serra A, Mozgunov P, Jaki T. An order restricted multi-arm multi-stage clinical trial design. Stat Med 2022. [PMID: 35048391 DOI: 10.1002/sim.9314] [Reference Citation Analysis]
4 Wilson N, Biggs K, Bowden S, Brown J, Dimairo M, Flight L, Hall J, Hockaday A, Jaki T, Lowe R, Murphy C, Pallmann P, Pilling MA, Snowdon C, Sydes MR, Villar SS, Weir CJ, Welburn J, Yap C, Maier R, Hancock H, Wason JMS. Costs and staffing resource requirements for adaptive clinical trials: quantitative and qualitative results from the Costing Adaptive Trials project. BMC Med 2021;19:251. [PMID: 34696781 DOI: 10.1186/s12916-021-02124-z] [Reference Citation Analysis]
5 Sverdlov O, Ryeznik Y, Wong WK. Opportunity for efficiency in clinical development: An overview of adaptive clinical trial designs and innovative machine learning tools, with examples from the cardiovascular field. Contemp Clin Trials 2021;105:106397. [PMID: 33845209 DOI: 10.1016/j.cct.2021.106397] [Reference Citation Analysis]
6 Skivington K, Matthews L, Simpson SA, Craig P, Baird J, Blazeby JM, Boyd KA, Craig N, French DP, McIntosh E, Petticrew M, Rycroft-Malone J, White M, Moore L. A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance. BMJ 2021;374:n2061. [PMID: 34593508 DOI: 10.1136/bmj.n2061] [Cited by in Crossref: 8] [Article Influence: 8.0] [Reference Citation Analysis]
7 Williamson SF, Jacko P, Jaki T. Generalisations of a Bayesian decision-theoretic randomisation procedure and the impact of delayed responses. Computational Statistics & Data Analysis 2021. [DOI: 10.1016/j.csda.2021.107407] [Reference Citation Analysis]